How leukemia is diagnosed

Leukemia is diagnosed through blood tests and bone marrow examination. A doctor starts with a complete blood count (CBC), which measures the number and type of cells in your blood. If the CBC shows abnormal white blood cell counts or immature cells, the next step is usually a bone marrow biopsy — a procedure where a needle removes a small sample of marrow from inside your bone so a pathologist can look at the cells under a microscope.

The bone marrow biopsy is the test that actually confirms leukemia. Blood tests alone can suggest it, but only marrow cells show whether the cancer is present and what type it is. Once leukemia is confirmed, additional tests identify which subtype you have — this matters because treatment depends on it.

Key Takeaways

  • A complete blood count (CBC) is the first test; it shows abnormal white blood cell numbers that prompt further investigation.
  • A bone marrow biopsy is the definitive test that confirms leukemia and identifies which type you have.
  • Flow cytometry and cytochemical stains examine the actual cells to determine the specific subtype and guide treatment.
  • Chromosome and genetic tests (cytogenetics and molecular testing) reveal mutations that affect prognosis and which drugs will work.
  • Imaging and lumbar puncture may follow diagnosis to check whether leukemia has spread to other organs or the brain.

The complete blood count (CBC)

The CBC is a routine blood test that counts how many of each type of cell you have. In leukemia, the white blood cell count is usually very high — sometimes 10 times normal or more — and many of those cells are immature blasts instead of mature, functioning white blood cells. The CBC also often shows low red blood cell and platelet counts because leukemia cells crowd out the normal cells that make them.

A CBC takes a few hours to process and costs less than other tests. It is not enough to diagnose leukemia on its own, but it is specific enough that an abnormal result will send you to a hematologist (blood specialist) or oncologist for the next step. Some people have a CBC for an unrelated reason and discover leukemia this way.

Bone marrow biopsy and aspiration

A bone marrow biopsy removes a solid core of marrow tissue, usually from the back of your hip bone. An aspiration draws out liquid marrow through the same needle. Both are done at the same time in most cases. The procedure takes 10 to 15 minutes. You receive local anesthetic to numb the skin, but you may feel pressure or a brief sharp sensation when the needle enters the bone.

The marrow sample goes to a pathologist, who stains it and looks at the cells under a microscope. This is where leukemia is confirmed — the pathologist counts how many blasts are present and describes their appearance. If more than 20 percent of the cells are blasts, leukemia is diagnosed. The pathologist also notes the size, shape, and color of the cells, which helps identify the subtype.

Results typically come back in three to five business days, though some hospitals offer preliminary results within 24 hours. Pain after the procedure is usually mild and controlled with over-the-counter pain relievers. Bruising at the biopsy site is common and fades in one to two weeks.

Flow cytometry and cell staining

Flow cytometry is a machine test that sorts cells by their surface markers — proteins that act like ID badges. Leukemia cells have abnormal marker patterns that normal cells do not have. The test runs the marrow sample through a laser that reads these markers on thousands of individual cells, producing a detailed map of what types of cells are present.

Flow cytometry is fast and precise. It can identify the subtype of leukemia in hours and sometimes guides treatment decisions before the full pathology report is ready. Cytochemical stains are older tests that use colored dyes to highlight specific chemicals inside cells. They are less common now but still used in some labs, especially for acute myeloid leukemia (AML).

Chromosome and genetic tests

Once leukemia is confirmed, a sample of the marrow cells is sent for cytogenetics — a test that looks at the chromosomes under a microscope to see if any are missing, extra, or rearranged. Leukemia cells often have specific chromosome changes. For example, chronic myeloid leukemia (CML) almost always has the Philadelphia chromosome, which is a piece of chromosome 9 stuck to chromosome 22.

Molecular testing (also called genetic sequencing or mutation testing) looks for specific gene mutations in the leukemia cells. It is more detailed than cytogenetics and can find mutations that cytogenetics misses. These tests take one to two weeks but are crucial because certain mutations determine which drugs will work and how aggressive the leukemia is likely to be.

Insurance usually covers both cytogenetics and molecular testing because the results directly affect treatment. If cost is a concern, ask your oncologist whether the lab offers a payment plan or whether the test can be prioritized — some mutations are more urgent to know than others.

Imaging and tests for spread

After leukemia is diagnosed, your doctor may order imaging to check whether it has spread. A chest X-ray looks for enlarged lymph nodes or fluid in the lungs. A CT scan of the chest and abdomen gives more detail if the X-ray is abnormal. These are not always necessary — many people with leukemia have no spread visible on imaging — but they establish a baseline for comparison later.

A lumbar puncture (spinal tap) may be done if your doctor suspects leukemia has reached the brain or spinal cord, or as a preventive measure in acute leukemias where this is common. A needle removes a small amount of cerebrospinal fluid (CSF) from around the spine, which is checked for leukemia cells. This test is more common in acute lymphoblastic leukemia (ALL) than in other types.

What happens after diagnosis tests are complete

Once all tests are back, your oncologist will have a complete picture: the type of leukemia, the specific mutations, whether it has spread, and how fast it is likely to grow. This information determines your treatment plan. Some people start chemotherapy within days; others may be monitored first if the leukemia is slow-growing.

You will also have baseline tests of kidney and heart function before treatment starts, because some chemotherapy drugs can damage these organs. Your doctor will explain what these results mean for your specific situation and what to expect from treatment.

Frequently Asked Questions

Does a bone marrow biopsy hurt?

You receive numbing medication, so you should not feel sharp pain, but you may feel pressure or a dull ache when the needle enters the bone. The procedure lasts 10 to 15 minutes. Pain afterward is usually mild and managed with acetaminophen or ibuprofen. Tell your doctor if you have anxiety about the procedure — they can discuss sedation options.

How long does it take to get a leukemia diagnosis?

A CBC takes hours. A bone marrow biopsy result comes back in three to five business days. Flow cytometry and initial pathology are often ready within 24 to 48 hours. Chromosome and genetic tests take one to two weeks. Your doctor can usually tell you the leukemia type and start treatment planning within a week of the biopsy.

Can leukemia be diagnosed from a blood test alone?

A blood test can strongly suggest leukemia, but a bone marrow biopsy is needed to confirm it and identify the exact type. Some people have very high blast counts in their blood, and a few labs will start treatment based on blood alone in urgent situations, but this is rare. The marrow biopsy is the standard diagnostic test.

What if the bone marrow biopsy does not show leukemia but my blood counts are still abnormal?

This can happen with other blood disorders that mimic leukemia. Your doctor may repeat the biopsy in a few weeks or months, or pursue other tests to identify what is causing the abnormal counts. Some conditions develop into leukemia over time, so monitoring is important.

Do I need all these tests, or can my doctor skip some?

The CBC and bone marrow biopsy are standard. Flow cytometry and cytogenetics are almost always done because they identify the subtype and guide treatment. Molecular testing is increasingly standard but may be skipped if cost is a barrier and the other tests already point to a clear diagnosis. Talk to your oncologist about which tests are essential for your situation.